Atosiban acetate composition and preparation method thereof

A technology of atosiban acetate and a composition, applied in the field of medicine, can solve the problems of complicated operation, poor medication safety, poor solubility and stability, etc., and achieve the effects of simple preparation method, high bioavailability and increased stability

Inactive Publication Date: 2017-01-04
HAINAN HERUI PHARMA
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, the solubility and stability of atosiban acetate on the market are relatively poor. In the prior art, solid-phase oxidation is used to simplify the process, but the obtained crude product has low purity, low yield, and low application value. Most of the reports on the synthesis process of atosiban adopt the Boc solid-phase synthesis route, cutting peptides with liquid ammonia, and then using liquid phase oxidation to purify atosiban acetate. The operation is complicated and produces a large amount of three wastes, which is not conducive to industrial production.
[0007] The patent of publication number CN102145162A discloses a kind of injection for the treatment of preterm labor medicine, and this preparation is made up of atosiban acetate, isotonic regulator, pH regulator, antioxidant, local analgesic and solvent, wherein a

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0043] Example 1

[0044] (1) At a temperature of 13°C, take 650 mL of water for injection and place it in a clean liquid preparation tank, add 60 mg of mannitol, and stir to dissolve it completely;

[0045] (2) Keep the temperature at 13°C, add 50mg of atosiban acetate raw material to the above solution, stir to make it completely dissolved;

[0046] (3) At 13°C, adjust the pH of the solution in step (2) with 1mol / L NaOH solution to 4.3, then add water for injection to 1000mL, and stir to make the mixture uniform;

[0047] (4) Keep the temperature of the solution unchanged at 13°C. After the solution is qualified, the solution is sterilized and filtered through a secondary 0.2μm filter into a sterilized medicine barrel;

[0048] (5) Filling, capping, and light inspection.

Example Embodiment

[0049] Example 2

[0050] (1) At a temperature of 15°C, take 700 mL of water for injection and place it in a clean liquid preparation tank, add 70 mg of mannitol, and stir to completely dissolve it;

[0051] (2) Keep the temperature at 15°C, add 60mg of atosiban acetate raw material to the above solution, stir to make it completely dissolved;

[0052] (3) At 15°C, adjust the pH of the solution in step (2) with 1mol / L NaOH solution to 4.5, then add water for injection to 1000mL, and stir to make the mixture uniform;

[0053] (4) Keep the temperature of the solution unchanged at 15°C. After the solution is qualified, the solution is sterilized and filtered through a secondary 0.2μm filter into a sterilized medicine barrel;

[0054] (5) Filling, capping, and light inspection.

Example Embodiment

[0055] Example 3

[0056] (1) At a temperature of 17°C, take 750 mL of water for injection and place it in a clean liquid preparation tank, add 90 mg of mannitol, and stir to dissolve it completely;

[0057] (2) Keep the temperature at 17°C, add 80mg of atosiban acetate raw material to the above solution, stir to completely dissolve it;

[0058] (3) Adjust the pH value of the solution in step (2) with 1mol / L NaOH solution at 17°C to 4.7, then add water for injection to 1000mL, and stir to make the mixture uniform;

[0059] (4) Keep the temperature of the solution at 17°C, take the solution and pass the test, sterilize and filter the solution through a secondary 0.2μm filter into the sterilized container;

[0060] (5) Filling, capping, and light inspection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an atosiban acetate composition. The composition is prepared from atosiban acetate, mannitol and sodium hydroxide. The invention provides a novel atosiban acetate composition which is safe in medication, can be used for remarkably inhibiting the uterine contraction effect, does not have side effects, does not need addition of antioxidants, and has good stability. The invention provides a method for preparing an atosiban acetate injection. By adopting the method, the temperature is constant in the whole liquid preparing process, and the prepared atosiban acetate injection has stable performance and has better stability after being stored for a long time.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner HAINAN HERUI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products